Capucine Robert

Capucine Robert is a Clinical Trial Associate at the Global Antibiotic R&D Partnership (GARDP) since December 2022, contributing to a phase 3 study in sexually transmitted infections. Prior to this role, Capucine served as an Associate Clinical Trial Manager at ObsEva SA, managing phase III studies in obstetrics across the EU and US from June 2019 to November 2022. Previous experience includes a traineeship as a Research Collaborator at CHUV in the Oncology Department, an Instrument Validation Engineer role at Quotient Limited, and various positions within Merck Group, Novartis Consumer Health, Vifor Pharma, and Celgene focusing on quality control, analytical development, and research. Capucine's educational background includes a clinical research training at CHUV and a master's degree in chemistry from the University of Sciences and Technologies of Franche Comté, complemented by ongoing coursework through Coursera.